Scientific deep-dive
Ozempic and Low Blood Sugar (Hypoglycemia): Risk, Symptoms and What to Do (2026)
Ozempic (semaglutide) alone has a low risk of hypoglycemia because it lowers glucose in a glucose-dependent way. When low blood sugar is a real risk (insulin and sulfonylureas), the warning symptoms, the 15-15 rule, when it's a 911 emergency, and how to prevent it.
Semaglutide by itself carries a low risk of low blood sugar (hypoglycemia). That is by design: it is glucose-dependent, meaning it stimulates the pancreas to release insulin mainly when blood sugar is high and the effect tapers off as glucose falls toward normal — so it does not keep pushing glucose down the way insulin does.[1] The real risk shows up when Ozempic is combined with insulin or a sulfonylurea — drugs like glipizide, glimepiride, or glyburide that force insulin release regardless of your glucose level. The FDA prescribing information warns that adding semaglutide to one of these can raise hypoglycemia risk, and that a dose reduction of the insulin or sulfonylurea may be needed to lower it.[1] On top of that, the appetite suppression that makes Ozempic effective can lead to skipped meals and under-eating, and alcohol, intense exercise, or gastrointestinal side effects that cut your food intake can all contribute. This guide explains who is actually at risk, how to recognize low blood sugar, how to treat it (the 15-15 rule), when a low is a 911 emergency, and the prescriber-directed steps that prevent it. Ozempic is semaglutide; see our Ozempic drug page and the broader Ozempic side effects guide for the full picture. This is general educational information, not medical advice — your prescriber manages your care.
About this article
The claims below about hypoglycemia risk and the advice to reduce the dose of insulin or a sulfonylurea were verified against the FDA prescribing information on DailyMed (NIH) — the Warnings and Precautions and the dosing sections of the Ozempic and Wegovy (semaglutide) labels — not an AI paraphrase or a third-party drug-monograph site. The glucose-dependent mechanism and the symptoms and treatment of hypoglycemia draw on the same labels, the MedlinePlus consumer summary for semaglutide, and a peer-reviewed American Diabetes Association and Endocrine Society workgroup report on hypoglycemia in diabetes. Hypoglycemia risk varies a great deal by person — whether you have diabetes at all, which other glucose-lowering drugs you take, and your eating and activity patterns — so treat this as general background and follow your own prescriber's plan. For the full side-effect profile see Ozempic side effects and the Ozempic drug page. This is general information, not medical advice — your prescriber individualizes your care.
Does Ozempic cause low blood sugar?
Mostly no, when it is taken on its own. Semaglutide belongs to the GLP-1 receptor agonist class, and these drugs lower glucose in a glucose-dependent way: they boost the body's own insulin response and blunt glucagon mainly when blood sugar is elevated, and that action eases off as glucose drops toward normal. Because the drug is not forcing insulin out regardless of your level, semaglutide alone carries a low risk of hypoglycemia.[1] That is one of the practical advantages of the class compared with older diabetes drugs that push glucose down whether or not it is needed.
The picture changes when semaglutide is added to insulin or to an insulin secretagogue such as a sulfonylurea — for example glipizide, glimepiride, or glyburide. These medications increase insulin in a way that is not glucose-dependent, so they can drive blood sugar too low on their own, and stacking semaglutide's glucose-lowering on top raises the combined risk. For this reason the FDA prescribing information states that the risk of hypoglycemia is increased when semaglutide is used with insulin or a sulfonylurea, and that lowering the dose of the insulin or sulfonylurea may be needed to reduce that risk.[1] Any such change is a decision for your prescriber, not something to do on your own. The same MedlinePlus consumer summary that lists semaglutide's side effects also describes the symptoms of low blood sugar and what to do about them.[3]
Who is actually at risk?
Risk is not uniform. The single biggest factor is what other glucose-lowering medicine you take alongside Ozempic, but several everyday situations can add to it:
- People also taking insulin or a sulfonylurea. This is the main risk group. Sulfonylureas include glipizide, glimepiride, and glyburide. When semaglutide is added to either, the label advises that the insulin or sulfonylurea dose may need to be reduced — a prescriber-directed adjustment.[1]
- People skipping meals or under-eating. Ozempic works by cutting appetite, and going too long without food — or eating far less than usual, especially early on — can let glucose drift low, particularly if you also take a glucose-lowering drug.[3]
- People drinking alcohol. Alcohol can impair the liver's ability to release glucose and can mask or mimic the warning signs of a low, so it can both cause and hide hypoglycemia.[4]
- People doing intense or unaccustomed exercise. Vigorous activity uses up glucose and can lower blood sugar for hours afterward, which matters most for those on insulin or a sulfonylurea.[4]
- People with significant GI side effects. Nausea, vomiting, or diarrhea that cut your food intake can leave you under-fueled, an indirect route to a low.[1]
By contrast, a person without diabetes who takes semaglutide for weight management, and who is not on insulin or a sulfonylurea, rarely develops true hypoglycemia — clinically confirmed low blood glucose. That distinction matters, and we return to it below, because feeling shaky from under-eating is not the same thing as a measured low.
Symptoms of low blood sugar
Low blood sugar tends to announce itself with a fairly recognizable cluster of symptoms. They can come on quickly. Learn to spot the early ones so you can treat a mild low before it becomes severe:[3][4]
- Shakiness or trembling
- Sweating, sometimes with clammy or cool skin
- Fast or pounding heartbeat
- Hunger, sometimes sudden and intense
- Dizziness or lightheadedness
- Confusion or trouble concentrating
- Irritability, anxiety, or mood change
- Blurred vision
- Headache, weakness, or fatigue
Severe hypoglycemia is an emergency
A severe low can progress to marked confusion, slurred speech, loss of coordination, seizures, or loss of consciousness — the person may be unable to swallow or treat themselves safely. This is a medical emergency. If someone with low blood sugar cannot safely eat or drink, is unconscious, or is having a seizure, do not put food or drink in their mouth. If glucagon (an emergency rescue medicine — injection or nasal) is available and you know how to use it, give it, and call 911 right away. People at risk of severe lows, particularly those on insulin or a sulfonylurea, should ask their prescriber whether they should carry a glucagon kit and make sure family or coworkers know how to use it. This panel is general safety information, not a substitute for your clinician's emergency plan.
How to treat a mild low: the 15-15 rule
For a mild-to-moderate low where you are awake and able to swallow safely, the widely taught approach is the 15-15 rule. The idea is to take a measured amount of fast-acting carbohydrate, give it time to work, and recheck — rather than overcorrecting and sending your glucose too high:[4]
- Take about 15 grams of fast-acting carbohydrate. Good options are glucose tablets or gel (the most reliable), about half a cup (4 ounces) of fruit juice or regular, non-diet soda, or a tablespoon of sugar or honey. Fast carbs work better here than fat-rich foods like chocolate, which are absorbed more slowly.
- Wait about 15 minutes to let the carbohydrate raise your blood sugar.
- Recheck your blood sugar if you have a meter or CGM. If it is still low, repeat the 15 grams and wait another 15 minutes.
- Once you are back to normal, eat a small balanced snack or meal if your next meal is more than an hour away, to keep glucose from dropping again.
- If you cannot get the low to come up, or symptoms are worsening, treat it as severe — glucagon and 911 as above.
If you do not have a glucose meter and you suspect a low, it is reasonable to treat with fast carbs and then check in with your prescriber about whether you should be monitoring. Recurrent lows are a signal that your overall regimen — usually the insulin or sulfonylurea dose — needs to be revisited.[1]
Preventing low blood sugar on Ozempic
Prevention targets the same drivers. The following are general, commonly-discussed strategies, and the medication-related ones are strictly prescriber-directed — do not change your Ozempic dose, your insulin, or your sulfonylurea on your own:
- Review your other diabetes medicines with your prescriber. If you take insulin or a sulfonylurea (glipizide, glimepiride, glyburide), ask whether those doses should be lowered when you start or increase semaglutide — the label specifically flags this as a way to reduce hypoglycemia risk.[1]
- Do not skip meals. Appetite suppression makes it easy to under-eat. Aim for regular, balanced meals even when the hunger cue is gone, so your glucose has a steadier supply.[3]
- Monitor your glucose, especially early on. A fingerstick meter or a continuous glucose monitor (CGM) helps you catch lows and learn your patterns, most usefully in the first weeks and after any dose change — discuss the right monitoring plan with your prescriber.[4]
- Carry fast-acting carbohydrate. Keep glucose tablets, juice, or another quick sugar source with you, particularly if you are on insulin or a sulfonylurea, so you can treat a low immediately.[4]
- Be cautious with alcohol. Alcohol can lower blood sugar and mask the warning signs; if you drink, do so with food and be especially watchful, particularly in the hours afterward.[4]
- Plan around exercise. Intense or longer-than-usual activity can lower glucose during and after; check before and after if you are at risk, and ask your prescriber how to adjust food or medication timing.[4]
- Mind your driving. Do not drive if you feel a low coming on; treat it, confirm your glucose has recovered, and only then get behind the wheel.[4]
If dizziness or lightheadedness is part of the picture, some of it can come from the low itself and some from other causes like dehydration — our Ozempic and dizziness guide untangles the overlapping drivers. For the full list of what is common versus serious, see Ozempic side effects.
Weight-loss use without diabetes: shaky is not the same as a low
This is a point of frequent confusion. People taking semaglutide for weight loss who do not have diabetes — and who are not on insulin or a sulfonylurea — rarely experience true hypoglycemia, meaning a measured, clinically low blood glucose. What they often do feel is shakiness, lightheadedness, or weakness from under-eating: the drug suppresses appetite so effectively that they go too long without food or eat far less than their body needs, and that can produce hunger-related, low-fuel symptoms that feel like a low without the blood glucose actually being in the hypoglycemic range.
The practical difference matters because the fix is different. For under-eating symptoms, the answer is usually eating regular, balanced meals rather than treating an emergency. For a genuine low — most likely in someone on insulin or a sulfonylurea — the answer is the 15-15 rule and, if severe, glucagon and 911. If you are unsure which you are dealing with, a glucose check settles it, and persistent symptoms are worth raising with your prescriber. If you are choosing where to start or continue semaglutide under proper supervision, compare the best semaglutide providers — a legitimate provider reviews your other medications, sets a monitoring plan, and follows up on symptoms exactly like these.
References
- 1.Novo Nordisk Inc. OZEMPIC (semaglutide) injection, for subcutaneous use — US Prescribing Information, §5 Warnings and Precautions and §2 Dosage and Administration (hypoglycemia with concomitant use of insulin or an insulin secretagogue such as a sulfonylurea; consider lowering the dose of the insulin or sulfonylurea to reduce the risk). DailyMed (NIH). 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
- 2.Novo Nordisk Inc. WEGOVY (semaglutide) injection, for subcutaneous use — US Prescribing Information, §5 Warnings and Precautions (increased risk of hypoglycemia when used with insulin or an insulin secretagogue, with a dose reduction of those agents that may be needed). DailyMed (NIH). 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- 3.U.S. National Library of Medicine (MedlinePlus) Semaglutide Injection — consumer drug information, including the symptoms of low blood sugar, the importance of not skipping meals, and guidance to contact a prescriber if a side effect is severe or does not go away. MedlinePlus (NIH). 2025. https://medlineplus.gov/druginfo/meds/a618008.html
- 4.Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society — definitions, symptoms, risk factors (insulin and secretagogues, alcohol, exercise), and treatment of hypoglycemia. Diabetes Care. 2013. PMID: 23589542.
Where to get semaglutide (Ozempic / Wegovy): vetted providers
Vetted telehealth providers that prescribe online, ranked by our editorial score. We compare pricing, form, and states served.
No insurance needed · vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Enhance MD
Lab-monitored compounded GLP-1 with mandatory video visit
From $212/mo
Get started →Strut Health
Oral-lozenge compounded GLP-1 access
From $99/mo
Get started →Get Thin MD
Lowest-priced compounded semaglutide on a 3-month commitment, with brand-name Ozempic/Zepbound also available
From $199/mo
Get started →